 Reza Hakkak
Concepts (246)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Soybean Proteins | 13 | 2024 | 153 | 3.660 |
Why?
| | Isoflavones | 7 | 2023 | 83 | 2.720 |
Why?
| | Obesity | 16 | 2024 | 1179 | 2.650 |
Why?
| | Rats, Zucker | 16 | 2024 | 74 | 2.410 |
Why?
| | Fatty Liver | 4 | 2023 | 129 | 2.190 |
Why?
| | Caseins | 8 | 2023 | 73 | 1.790 |
Why?
| | Rats | 35 | 2024 | 3417 | 1.700 |
Why?
| | Liver | 15 | 2023 | 1226 | 1.630 |
Why?
| | Colon | 4 | 2024 | 111 | 1.610 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 6 | 2015 | 54 | 1.220 |
Why?
| | Mammary Neoplasms, Experimental | 5 | 2010 | 135 | 1.110 |
Why?
| | Animals | 40 | 2024 | 14402 | 1.020 |
Why?
| | Thinness | 3 | 2017 | 57 | 0.970 |
Why?
| | Hepatitis | 1 | 2024 | 22 | 0.970 |
Why?
| | Acute-Phase Proteins | 1 | 2024 | 26 | 0.970 |
Why?
| | Diet | 9 | 2019 | 584 | 0.960 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 201 | 0.890 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 270 | 0.870 |
Why?
| | Metformin | 1 | 2023 | 66 | 0.860 |
Why?
| | Carrier Proteins | 1 | 2024 | 360 | 0.830 |
Why?
| | Inflammation | 3 | 2024 | 679 | 0.830 |
Why?
| | Anticarcinogenic Agents | 2 | 2017 | 35 | 0.770 |
Why?
| | Carcinogens | 7 | 2015 | 231 | 0.760 |
Why?
| | Lactobacillaceae | 1 | 2020 | 2 | 0.740 |
Why?
| | Body Weight | 10 | 2023 | 574 | 0.730 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 75 | 0.700 |
Why?
| | Ethanol | 10 | 2004 | 323 | 0.610 |
Why?
| | Butyrates | 1 | 2017 | 35 | 0.580 |
Why?
| | Ovariectomy | 2 | 2014 | 127 | 0.560 |
Why?
| | Oxidoreductases, N-Demethylating | 6 | 2000 | 19 | 0.520 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2024 | 435 | 0.510 |
Why?
| | Dietary Supplements | 3 | 2019 | 452 | 0.510 |
Why?
| | Cytochrome P-450 Enzyme System | 7 | 2001 | 192 | 0.500 |
Why?
| | Plant Extracts | 1 | 2017 | 192 | 0.500 |
Why?
| | Receptors, Leptin | 1 | 2014 | 47 | 0.490 |
Why?
| | Tibia | 1 | 2014 | 117 | 0.480 |
Why?
| | Osteoporosis | 2 | 2019 | 164 | 0.480 |
Why?
| | Arginine | 1 | 2015 | 182 | 0.470 |
Why?
| | Lumbar Vertebrae | 1 | 2014 | 105 | 0.460 |
Why?
| | Cell Proliferation | 1 | 2017 | 1097 | 0.430 |
Why?
| | Mammary Neoplasms, Animal | 2 | 2015 | 38 | 0.430 |
Why?
| | Osteocytes | 1 | 2014 | 219 | 0.410 |
Why?
| | Rats, Sprague-Dawley | 20 | 2015 | 1664 | 0.390 |
Why?
| | Milk Proteins | 4 | 2001 | 77 | 0.390 |
Why?
| | Dehydroepiandrosterone | 1 | 2010 | 16 | 0.380 |
Why?
| | Male | 25 | 2024 | 27335 | 0.380 |
Why?
| | Colonic Neoplasms | 3 | 2001 | 164 | 0.380 |
Why?
| | Benz(a)Anthracenes | 1 | 2010 | 35 | 0.370 |
Why?
| | Soy Foods | 1 | 2009 | 23 | 0.350 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2010 | 96 | 0.350 |
Why?
| | Interleukin-6 | 2 | 2023 | 315 | 0.320 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 34 | 0.310 |
Why?
| | Protons | 1 | 2007 | 81 | 0.290 |
Why?
| | Gene Expression | 2 | 2019 | 664 | 0.290 |
Why?
| | Female | 16 | 2023 | 28457 | 0.290 |
Why?
| | Dietary Proteins | 4 | 2001 | 230 | 0.270 |
Why?
| | Bone Density | 3 | 2019 | 416 | 0.270 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 4 | 2001 | 70 | 0.250 |
Why?
| | Azoxymethane | 3 | 2001 | 8 | 0.250 |
Why?
| | Diet, Reducing | 1 | 2024 | 38 | 0.240 |
Why?
| | Metabolome | 1 | 2023 | 108 | 0.210 |
Why?
| | C-Reactive Protein | 1 | 2023 | 159 | 0.210 |
Why?
| | Cytokine Receptor Common beta Subunit | 1 | 2019 | 2 | 0.180 |
Why?
| | Methyltransferases | 1 | 2019 | 29 | 0.180 |
Why?
| | Breast Neoplasms | 1 | 2009 | 1248 | 0.180 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 116 | 0.180 |
Why?
| | Proteomics | 1 | 2021 | 343 | 0.170 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 531 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2020 | 207 | 0.160 |
Why?
| | Alcohol Drinking | 2 | 1999 | 259 | 0.160 |
Why?
| | Diet, High-Fat | 1 | 2020 | 216 | 0.160 |
Why?
| | Osteogenesis | 2 | 2019 | 377 | 0.150 |
Why?
| | HCT116 Cells | 1 | 2017 | 27 | 0.150 |
Why?
| | Enteral Nutrition | 3 | 2000 | 135 | 0.150 |
Why?
| | Feces | 1 | 2017 | 136 | 0.140 |
Why?
| | DNA Fragmentation | 1 | 2017 | 67 | 0.140 |
Why?
| | Adiponectin | 1 | 2017 | 76 | 0.140 |
Why?
| | Alanine Transaminase | 2 | 2015 | 151 | 0.140 |
Why?
| | Liver Neoplasms, Experimental | 1 | 1996 | 48 | 0.140 |
Why?
| | Phylogeny | 1 | 2017 | 269 | 0.140 |
Why?
| | Gastrointestinal Neoplasms | 1 | 1996 | 46 | 0.140 |
Why?
| | Lipid Metabolism | 1 | 2017 | 194 | 0.140 |
Why?
| | Protein Hydrolysates | 1 | 2015 | 5 | 0.130 |
Why?
| | Leptin | 1 | 2017 | 154 | 0.130 |
Why?
| | Aspartate Aminotransferases | 1 | 2015 | 57 | 0.130 |
Why?
| | Cytochrome P-450 CYP2E1 | 6 | 2004 | 105 | 0.130 |
Why?
| | Insulin | 1 | 2017 | 510 | 0.120 |
Why?
| | Isoenzymes | 2 | 2000 | 176 | 0.120 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2004 | 35 | 0.120 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 2002 | 0.120 |
Why?
| | Absorptiometry, Photon | 1 | 2014 | 173 | 0.120 |
Why?
| | Cell Line | 1 | 2017 | 1152 | 0.120 |
Why?
| | Dietary Carbohydrates | 3 | 2004 | 90 | 0.110 |
Why?
| | Dietary Fats | 3 | 2004 | 138 | 0.110 |
Why?
| | Intestine, Small | 1 | 1993 | 123 | 0.110 |
Why?
| | Humans | 9 | 2019 | 54304 | 0.100 |
Why?
| | Time Factors | 4 | 2007 | 3207 | 0.090 |
Why?
| | Cytoprotection | 1 | 2010 | 48 | 0.090 |
Why?
| | Central Nervous System Depressants | 3 | 2002 | 78 | 0.090 |
Why?
| | Apoptosis | 1 | 2017 | 1302 | 0.090 |
Why?
| | Disease Models, Animal | 4 | 2019 | 1651 | 0.090 |
Why?
| | Parenteral Nutrition, Total | 2 | 2002 | 26 | 0.090 |
Why?
| | Cytochrome P-450 CYP1A1 | 3 | 2001 | 46 | 0.090 |
Why?
| | Organ Size | 3 | 2007 | 237 | 0.090 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2010 | 158 | 0.090 |
Why?
| | Signal Transduction | 1 | 2017 | 1751 | 0.090 |
Why?
| | Mice | 2 | 2020 | 6428 | 0.090 |
Why?
| | Tissue Extracts | 1 | 2007 | 13 | 0.080 |
Why?
| | Least-Squares Analysis | 1 | 2007 | 45 | 0.080 |
Why?
| | Solubility | 1 | 2007 | 74 | 0.080 |
Why?
| | Biotransformation | 1 | 2007 | 100 | 0.080 |
Why?
| | Estrogens | 1 | 2009 | 244 | 0.080 |
Why?
| | Bone and Bones | 2 | 2019 | 515 | 0.070 |
Why?
| | RNA, Messenger | 5 | 2001 | 1203 | 0.070 |
Why?
| | Aging | 2 | 2010 | 782 | 0.070 |
Why?
| | Adenocarcinoma | 2 | 2001 | 428 | 0.070 |
Why?
| | Enzyme Induction | 4 | 2001 | 80 | 0.070 |
Why?
| | Apoproteins | 2 | 1996 | 11 | 0.070 |
Why?
| | Cytochrome P-450 CYP1A2 | 2 | 2001 | 46 | 0.060 |
Why?
| | Body Mass Index | 1 | 2007 | 705 | 0.060 |
Why?
| | Asthma | 1 | 2007 | 293 | 0.060 |
Why?
| | Fatty Acids | 1 | 2004 | 175 | 0.060 |
Why?
| | Pregnancy | 3 | 2015 | 2637 | 0.060 |
Why?
| | Receptors, Glucocorticoid | 2 | 1993 | 36 | 0.060 |
Why?
| | Energy Intake | 2 | 2019 | 183 | 0.060 |
Why?
| | Cell Membrane | 1 | 2004 | 279 | 0.050 |
Why?
| | Overweight | 1 | 2005 | 235 | 0.050 |
Why?
| | Infant Food | 1 | 2002 | 31 | 0.050 |
Why?
| | Safrole | 1 | 2001 | 3 | 0.050 |
Why?
| | Mammary Glands, Animal | 1 | 2001 | 69 | 0.050 |
Why?
| | Methylcholanthrene | 1 | 2001 | 10 | 0.050 |
Why?
| | Cytochrome P-450 CYP3A | 3 | 2000 | 82 | 0.050 |
Why?
| | Food, Formulated | 1 | 2001 | 44 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2001 | 230 | 0.050 |
Why?
| | Blotting, Western | 3 | 2001 | 684 | 0.050 |
Why?
| | Risk Factors | 1 | 2009 | 3934 | 0.050 |
Why?
| | Cell Division | 1 | 2001 | 330 | 0.050 |
Why?
| | Chemoprevention | 1 | 2000 | 16 | 0.050 |
Why?
| | Cytochrome P-450 CYP2B1 | 1 | 1999 | 6 | 0.050 |
Why?
| | Phytoestrogens | 1 | 2019 | 20 | 0.040 |
Why?
| | Osteocalcin | 1 | 2019 | 46 | 0.040 |
Why?
| | Vagina | 1 | 2000 | 48 | 0.040 |
Why?
| | Cattle | 1 | 2000 | 224 | 0.040 |
Why?
| | Hepatitis, Alcoholic | 1 | 1999 | 9 | 0.040 |
Why?
| | Femur | 1 | 2019 | 144 | 0.040 |
Why?
| | Steroid Hydroxylases | 2 | 2000 | 12 | 0.040 |
Why?
| | Oxidoreductases | 2 | 2001 | 62 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2000 | 634 | 0.040 |
Why?
| | Weight Gain | 1 | 2000 | 241 | 0.040 |
Why?
| | Amino Acids | 1 | 2019 | 369 | 0.040 |
Why?
| | Cocarcinogenesis | 1 | 1996 | 13 | 0.040 |
Why?
| | Duodenal Neoplasms | 1 | 1996 | 15 | 0.040 |
Why?
| | Incidence | 1 | 2000 | 1083 | 0.040 |
Why?
| | Digitoxin | 1 | 1975 | 5 | 0.030 |
Why?
| | Immunoenzyme Techniques | 1 | 1996 | 166 | 0.030 |
Why?
| | Nitrophenols | 1 | 1995 | 15 | 0.030 |
Why?
| | Carbon Tetrachloride | 1 | 1995 | 20 | 0.030 |
Why?
| | Lymphocytes | 1 | 1996 | 168 | 0.030 |
Why?
| | Protective Agents | 1 | 2015 | 20 | 0.030 |
Why?
| | Growth | 1 | 1995 | 43 | 0.030 |
Why?
| | Rats, Wistar | 1 | 1995 | 237 | 0.030 |
Why?
| | Microsomes, Liver | 1 | 1975 | 214 | 0.030 |
Why?
| | Dental Pulp Necrosis | 1 | 1974 | 1 | 0.030 |
Why?
| | Periapical Granuloma | 1 | 1974 | 1 | 0.030 |
Why?
| | Radicular Cyst | 1 | 1974 | 3 | 0.030 |
Why?
| | Root Canal Therapy | 1 | 1974 | 3 | 0.030 |
Why?
| | Pulsatile Flow | 1 | 1993 | 18 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1993 | 83 | 0.030 |
Why?
| | Homeostasis | 1 | 1993 | 220 | 0.030 |
Why?
| | Leiomyosarcoma | 1 | 1992 | 25 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 1993 | 564 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2007 | 94 | 0.020 |
Why?
| | Hand Injuries | 1 | 1976 | 24 | 0.020 |
Why?
| | Cnidaria | 1 | 1976 | 2 | 0.020 |
Why?
| | Sterols | 1 | 1976 | 7 | 0.020 |
Why?
| | Exercise Therapy | 1 | 1976 | 121 | 0.020 |
Why?
| | Dexamethasone | 2 | 1999 | 435 | 0.020 |
Why?
| | Burns | 1 | 1976 | 170 | 0.020 |
Why?
| | Corn Oil | 1 | 2004 | 13 | 0.020 |
Why?
| | Free Radicals | 1 | 2004 | 31 | 0.020 |
Why?
| | Glucocorticoids | 2 | 1999 | 234 | 0.020 |
Why?
| | Malondialdehyde | 1 | 2004 | 63 | 0.020 |
Why?
| | Antibodies | 1 | 2004 | 178 | 0.010 |
Why?
| | Glutathione | 1 | 2004 | 330 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 2002 | 27 | 0.010 |
Why?
| | Asia | 1 | 2002 | 32 | 0.010 |
Why?
| | Tumor Cells, Cultured | 2 | 1993 | 477 | 0.010 |
Why?
| | Bone Development | 1 | 2002 | 69 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2007 | 1693 | 0.010 |
Why?
| | Antioxidants | 1 | 2004 | 297 | 0.010 |
Why?
| | Fertilization | 1 | 2001 | 5 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 401 | 0.010 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2001 | 29 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2001 | 108 | 0.010 |
Why?
| | Chlorzoxazone | 1 | 2000 | 4 | 0.010 |
Why?
| | Cytosol | 1 | 2001 | 101 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 677 | 0.010 |
Why?
| | Substrate Specificity | 1 | 2000 | 207 | 0.010 |
Why?
| | Oxygenases | 1 | 1999 | 10 | 0.010 |
Why?
| | Health Status | 1 | 2002 | 368 | 0.010 |
Why?
| | Alcoholism | 1 | 2002 | 249 | 0.010 |
Why?
| | Food-Drug Interactions | 1 | 1999 | 13 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2004 | 956 | 0.010 |
Why?
| | Necrosis | 1 | 1999 | 208 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 4161 | 0.010 |
Why?
| | CD4-CD8 Ratio | 1 | 1996 | 6 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 1996 | 23 | 0.010 |
Why?
| | Antigens, Surface | 1 | 1996 | 55 | 0.010 |
Why?
| | Thymus Gland | 1 | 1996 | 45 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2001 | 1064 | 0.010 |
Why?
| | Digitoxigenin | 1 | 1975 | 6 | 0.010 |
Why?
| | NADP | 1 | 1975 | 27 | 0.010 |
Why?
| | Chromatography, Thin Layer | 1 | 1975 | 32 | 0.010 |
Why?
| | Hydroxylation | 1 | 1975 | 61 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 187 | 0.010 |
Why?
| | Root Canal Filling Materials | 1 | 1974 | 2 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2002 | 2923 | 0.010 |
Why?
| | Formaldehyde | 1 | 1974 | 49 | 0.010 |
Why?
| | Centrifugation, Density Gradient | 1 | 1993 | 26 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1993 | 39 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1993 | 48 | 0.010 |
Why?
| | Triamcinolone Acetonide | 1 | 1993 | 16 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1993 | 43 | 0.010 |
Why?
| | Immunoassay | 1 | 1993 | 31 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 124 | 0.010 |
Why?
| | Flow Cytometry | 1 | 1996 | 547 | 0.010 |
Why?
| | Alcohol Dehydrogenase | 1 | 1993 | 31 | 0.010 |
Why?
| | Infant | 1 | 2002 | 3832 | 0.010 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 1992 | 16 | 0.010 |
Why?
| | Antigen-Antibody Complex | 1 | 1992 | 39 | 0.010 |
Why?
| | Radiography | 1 | 1974 | 526 | 0.010 |
Why?
| | Cricetinae | 1 | 1992 | 208 | 0.010 |
Why?
| | Down-Regulation | 1 | 1993 | 388 | 0.010 |
Why?
| | Neoplasms | 1 | 2002 | 1321 | 0.010 |
Why?
| | United States | 1 | 2002 | 5204 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 1992 | 360 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1992 | 868 | 0.000 |
Why?
| | Bandages | 1 | 1976 | 22 | 0.000 |
Why?
| | Chromatography, Gas | 1 | 1976 | 16 | 0.000 |
Why?
| | Methods | 1 | 1976 | 66 | 0.000 |
Why?
| | Lipids | 1 | 1976 | 178 | 0.000 |
Why?
| | Mass Spectrometry | 1 | 1976 | 313 | 0.000 |
Why?
| | Adolescent | 1 | 1974 | 6896 | 0.000 |
Why?
| | Aged | 1 | 1974 | 10054 | 0.000 |
Why?
| | Middle Aged | 1 | 1974 | 13076 | 0.000 |
Why?
| | Adult | 1 | 1974 | 14189 | 0.000 |
Why?
|
|
Hakkak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|